Clinical Trials Browser

INDUSTRY × Prednisolone × Clear all

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Lymphoma, Follicular

Prostatic Neoplasms

Adrenal Insufficiency, Myasthenia Gravis

Lymphoma, Follicular, Recurrence

Hodgkin Disease

Lymphoma, Large B-Cell, Diffuse

Lymphoma, B-Cell

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Metastatic Castration-resistant Prostate Cancer

Ovarian Neoplasms

Prostatic Neoplasms

Lymphoma, Follicular

Lymphoma, Large B-Cell, Diffuse

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Multiple Myeloma

Prostatic Neoplasms

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Prostatic Neoplasms

Lymphoma, Non-Hodgkin

Breast Neoplasms, Stomatitis, Oral Ulcer

Lymphoma, Large B-Cell, Diffuse

Advanced Cancer

Breast Neoplasms, Neoplasm Metastasis

Lymphoma, Follicular

Prostatic Neoplasms

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Follicular

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

Prostate Cancer Metastatic

Lymphoma, Follicular

Prostatic Neoplasms

Multiple Myeloma

Clinical Trials

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

MK-2140-010

MK-2400-001

OLYMPIA-1

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

OCTAGON

LEDA

MK-3475-667

OLYMPIA-3

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

rechARge

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

CYCLONE 3

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

IPATential150

KEYLYNK-010

PRESIDE

ERA 223

VCAT

waveLINE-007

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.

PLATO

A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma

Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus

First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer

PROSELICA

Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents

PEGAZUS

E3-Hormone Refractory Prostrate Cancer Taxotere Combination

VENICE

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

MUNIN

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)